Cleveland Clinic led trial shows drug effective in 96% of patients with recurrent pericarditis

EMBARGOED UNTIL 8:34 P.M. ET, Monday, November 16, 2020, Cleveland: Cleveland Clinic researchers leading a global clinical trial have found that rilonacept, an FDA approved drug for other inflammatory diseases, resolved acute pericarditis episodes and reduced risk of pericarditis recurrence. The study was published today in the New England Journal of Medicine and presented at…

Details

Biochar from agricultural waste products can adsorb contaminants in wastewater

UNIVERSITY PARK, Pa. — Biochar — a charcoal-like substance made primarily from agricultural waste products — holds promise for removing emerging contaminants such as pharmaceuticals from treated wastewater. That’s the conclusion of a team of researchers that conducted a novel study that evaluated and compared the ability of biochar derived from two common leftover agricultural…

Details

Omega-3 fatty acids vs corn oil, major adverse cardiovascular events in patients at high risk

What The Study Did: This randomized trial examines the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA and DHA (omega-3 CA) with documented favorable effects on lipid and inflammatory markers in patients with atherogenic dyslipidemia and high cardiovascular risk. Authors: Steven E. Nissen, M.D.,of the Cleveland Clinic Heart and Vascular Institute in Cleveland,…

Details